{"anticipatedPostingDate":"2010-03","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"}],"units":"Participants"}],"description":"Number of patients who discontinued deferasirox during 6 month daily treatment due to drug related toxicity","groups":[{"description":"Includes patients that were treated with deferasirox for 6 months.","id":"OG000","title":"Deferasirox Treated"}],"paramType":"NUMBER","populationDescription":"Note: 1 patient had a transient decrease in hemoglobin that required discontinuation of treatment for 2 weeks; subsequently restarted at same dose and completed therapy.","reportingStatus":"POSTED","timeFrame":"6 Months","title":"Number of Patients Not Completing Treatment","type":"PRIMARY","unitOfMeasure":"Participants"}